Demand:  In-vitro Models of Ginival  Tissue

The "TOP 10 Global Pharma Company" is seeking:

Novel in vitro models that mimic oral gingival tissue

They are looking for potential partners with unique innovative technologies to meet changing needs of global consumers. Seeker is the leading research-based pharmaceutical and healthcare company in the world, employing  100,000+  people in 100+  countries. 

Your product innovation combined with additional scientific expertise and world-class marketing can help them deliver innovative Consumer Healthcare brands around the world.  Seeker is committed to Open Innovation R&D  model.

Open Innovation is process for linking of external ideas or innovative technology with internal R&D and Commercial team responsible to grow new innovative and branded products. .

First you should  submit non-coofidential information about you innovative product or technology. Once submitted, your innovation idea is assigned to an Technology Transfer Manager at Farmavita.Net to guide the idea through early stage of assessment. After postive initial assessment of non-confidential information you will be asked to close the agency agreement with Farmavita.Net and to authorize us to manage you thorough the process of licensing negotiations. 

The ultimate goal of seeker is to in-license and commercializes innovative technologies, matching their strategic goals. Through appropriate legal agreements, seeker hope to link external innovative technology to their global brands – a process that can result in a win for product/technology seeker and a win for innovators.

• Cefdinir (12/02/2010)
• Cefixime (12/02/2010)
• Cefixime (12/02/2010)

• High-speed immune detection apparatus (10/04/2008)
• $10 Million X PRIZE (15/10/2006)
• Paclitaxel (19/07/2006)